Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,302
datasets available to search
ShareScore release 0.9.0
Dataset results
2,302 results for “B-cells”
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT00381680. IPD Sharing: YES. Countries: 4. Publications: 1.
A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)
ClinicalTrials.gov study NCT05460533. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL
ClinicalTrials.gov study NCT02055820. IPD Sharing: Not stated. Countries: 10. Publications: 3.
Study of Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Adults With Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT02926833. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
ClinicalTrials.gov study NCT01287741. IPD Sharing: Not stated. Countries: 29. Publications: 14.
Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients
ClinicalTrials.gov study NCT00086580. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
ClinicalTrials.gov study NCT00057811. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)
ClinicalTrials.gov study NCT04035434. IPD Sharing: NO. Countries: 6. Publications: 0.
A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)
ClinicalTrials.gov study NCT02018861. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma
ClinicalTrials.gov study NCT00924326. IPD Sharing: NO. Countries: 1. Publications: 10.
BGB 3111 in Combination With Obinutuzumab in Participants With B-Cell Lymphoid Malignancies
ClinicalTrials.gov study NCT02569476. IPD Sharing: YES. Countries: 3. Publications: 1.
Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma
ClinicalTrials.gov study NCT04836195. IPD Sharing: NO. Countries: 1. Publications: 2.
New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement
ClinicalTrials.gov study NCT02329080. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02703272. IPD Sharing: Not stated. Countries: 20. Publications: 2.
Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT00156013. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02285062. IPD Sharing: Not stated. Countries: 21. Publications: 3.
Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL)
ClinicalTrials.gov study NCT01294579. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03681535. IPD Sharing: NO. Countries: 6. Publications: 1.
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
ClinicalTrials.gov study NCT00910910. IPD Sharing: Not stated. Countries: 27. Publications: 1.
Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients
ClinicalTrials.gov study NCT01994850. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.